Standout Papers

<sup>18</sup>F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A... 2010 2026 2015 2020 499
  1. 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial (2010)
    Rik Vandenberghe, Koen Van Laere et al. Annals of Neurology

Immediate Impact

6 by Nobel laureates 7 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Hallmarks of neurodegenerative diseases
2023 Standout
Trial of Solanezumab in Preclinical Alzheimer’s Disease
2023 Standout
8 intermediate papers

Works of Alex Kørner being referenced

18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
2010 Standout

Author Peers

Author Last Decade Papers Cites
Alex Kørner 611 96 55 436 182 14 936
Freddy Ortiz 564 145 93 254 118 18 959
A. Dame 497 56 62 362 108 15 859
Ilona Hallikainen 487 78 73 238 174 30 804
Emile Franssen 643 134 69 257 58 22 998
Nancy R. Barbas 444 44 50 300 164 22 876
Guido F. Schauer 374 90 46 270 132 10 1.1k
Vijaya L. Melnick 390 101 48 312 54 8 834
Göran Hagman 508 40 24 545 126 31 946
Jong Choul Youn 434 60 46 214 161 16 767
Catherine Tunnard 517 43 124 265 119 20 855

All Works

Loading papers...

Rankless by CCL
2026